Medicare utilization — RAYMOND S. LANCE (M.D.)
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | 1,140 | 11 | $0 | $20,805 |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 484 | 308 | $0 | $31,231 |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 193 | 28 | $0 | $26,153 |
| 81002 | Urinalysis, manual test | 136 | 107 | $0 | $455 |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 130 | 121 | $0 | $12,684 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·